Official UK procurement notice
Provision of EPR services
Authority: NORTH CHESHIRE & MERSEY NHS FOUNDATION TRUST (NHS & healthcare)
North Cheshire & Mersey NHS Foundation Trust intends to enter into a contract with DH OpCo UK Ltd for the continued provision, support and maintenance of the Trust's existing Electronic Patient Record (EPR) services, including the Lorenzo and Ormis applications and associated existing interfaces, together with Lorenzo PatientAide and its associated implementation, configuration, support and maintenance services. Lorenzo PatientAide is an additional module and was not included within the Trust's original agreement. The proposed agreement is intended to preserve the safe and continuous operation of clinically critical EPR services while the Trust undertakes a compliant re-procurement and, if required, implements and transitions to a replacement solution. The Trust's existing arrangements contain options to extend the incumbent services beyond 23 November 2026 through up to two further 12-month periods, potentially providing continuity until November 2028.
What is being bought
Published requirement descriptionNorth Cheshire & Mersey NHS Foundation Trust intends to enter into a contract with DH OpCo UK Ltd for the continued provision, support and maintenance of the Trust's existing Electronic Patient Record (EPR) services, including the Lorenzo and Ormis applications and associated existing interfaces, together with Lorenzo PatientAide and its associated implementation, configuration, support and maintenance services.
Lorenzo PatientAide is an additional module and was not included within the Trust's original agreement.
The proposed agreement is intended to preserve the safe and continuous operation of clinically critical EPR services while the Trust undertakes a compliant re-procurement and, if required, implements and transitions to a replacement solution. The Trust may undertake that future procurement independently or in collaboration with another NHS organisation, depending on approved requirements and arrangements at that time.
The Trust's existing arrangements contain options to extend the incumbent services beyond 23 November 2026 through up to two further 12-month periods, potentially providing continuity until November 2028. While these provisions provide short-term flexibility, no further contractual extension rights exist beyond November 2028.
The proposed term reflects the Trust's current programme for procuring and implementing its future EPR arrangements, including the time required to complete the procurement, implementation, migration, integration, testing, training, clinical-safety assurance and transition activities.
The Trust has considered the extension rights available under the existing arrangements, including the potential for continuity until November 2028. However, those rights do not provide a reasonable alternative to the proposed contract. They expire before the Trust's revised EPR programme allows sufficient time to complete the planned EPR mini-competition and associated approval processes, and then safely implement the replacement solution, including configuration, data migration, integration, testing, training, clinical-safety assurance and deployment.
The additional period to 30 November 2029 is therefore required to maintain continuity while those activities are completed. Without it, the existing arrangements could end before the replacement EPR is operational, creating unacceptable clinical, operational and business-continuity risks.
The proposed term is a time-limited continuity measure to support transition to a replacement EPR and is not a longer-term commitment to the incumbent solution. The Trust does not consider competition to be permanently absent: the proposed direct award does not extend to the future replacement EPR, which is intended to be procured separately through competition.
Open work like this
This notice no longer takes bids · live search, filters set
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| DH OpCo UK Ltd (Dedalus)1 Dec 2026 – 30 Nov 2029Options: The agreement covers the continued provision, support and maintenance of the Lorenzo and Ormis applications and associated existing interfaces, together with the Lorenzo PatientAide module and associated services expressly described in this notice. Services necessary to operate, secure, maintain and support the contracted environment may be provided during the agreement period. The contract will be limited to the services and functionality described in this notice, together with the services reasonably necessary to operate, secure, maintain and support the identified Lorenzo, Ormis and PatientAide environment during the continuity period. It will not provide for materially new modules or functionality outside that scope. The agreement is not intended to provide an unrestricted mechanism for the procurement of materially new modules, functionality or significant expansion beyond the scope set out in this notice. The agreement will operate up to 30 November 2029. The Trust will keep the timetable for future procurement and transition under review and may exit earlier where this can be achieved safely, lawfully and operationally. Charges may be adjusted by agreed CPI indexation and permitted evidenced third-party cost changes, provided these are included within the published maximum estimated value. | £4,411,737 | 18 Nov 2026standstill to 27 Nov 2026 | Standstill |
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 16 Nov 2026, 09:07 GMT
- Last source update
- 18 Nov 2026, 10:13 GMT
- Authority reference
DS0184/ DS00185- FTS notice number
2026/S 000-109136- Latest notice
- Contract award notice (UK6)
- Delivery area
- Official registry OCID
ocds-h6vhtk-07bc40Find a Tender
- Why no open competition
- Single Suppliers Technical Reasons
- Published justification
The Trust considers that the conditions in paragraph 6 of Schedule 5 to the Procurement Act 2023 are met. Due to an absence of competition for technical reasons, only DH OpCo UK Ltd can supply the services required under the proposed contract, and there are no reasonable alternatives to those services.
For the continued Lorenzo and Ormis requirement, the Trust's assessment is that, because of the technical characteristics and dependencies of the incumbent EPR environment and the absence of a reasonable alternative capable of meeting the requirement without disproportionate technical, operational and clinical impact, only DH OpCo UK Ltd can provide the required continuity, authorised support and maintenance services.
The Lorenzo and Ormis environment is integrated with the Trust's wider digital estate through established clinical, operational, diagnostic, internal, external and national NHS interfaces. The incumbent applications contain supplier-controlled and product-specific elements, including configurations, data structures, workflows, interfaces and supported upgrade pathways.
Changing supplier for the incumbent environment would create disproportionate technical difficulties and material risk, including interface failure, incomplete or inaccurate data migration, disruption to clinical workflows and loss of continuity in clinically critical services.
The proposed agreement also includes Lorenzo PatientAide, which was not included within the Trust's original contractual arrangements.
Overall the Trust has considered whether the requirement could reasonably be met through alternative suppliers or a narrower solution including:
Immediate competitive procurement and full EPR replacement before incumbent continuity is required. This would not provide a safely implemented replacement in time and would require procurement, configuration, migration, integration, testing, training, clinical-safety assurance and deployment.
Appointment of a third party to support Lorenzo and Ormis. This is not reasonable unless that supplier can demonstrate lawful rights, authorised access, product-support capability, tooling, technical knowledge and the ability to assume responsibility for the integrated environment. No such reasonable alternative has been identified.
Procuring an alternative solution during the proposed continuity period would require additional integration, configuration, interoperability, data-flow, testing, clinical-safety assurance and implementation activity. This would introduce additional technical and operational dependencies and a risk of duplication and disruption during the period in which the Trust is maintaining the existing EPR environment pending procurement and transition to its future solution. On the basis of its technical assessment, the Trust has concluded that separate procurement of this functionality would not provide a reasonable alternative without disproportionate technical and operational impact.
Separate procurement of theatre functionality instead of Ormis. This would introduce an additional implementation and migration programme, require redevelopment and assurance of interfaces and could duplicate cost and transition activity.
A shorter or narrower continuity arrangement. The proposed scope and duration are intended to provide continuity while the Trust undertakes its future EPR procurement, implementation and clinically safe transition.
Use of an available framework or other competitive route. Competition remains intended for the future EPR solution but does not remove the present need for authorised incumbent support and safe continuity.
The Trust has concluded, on the evidence available at the date of decision, that these alternatives do not reasonably meet the current requirement with an acceptable level of technical, operational and clinical risk.
The EPR environment supports clinically critical and operational processes and exchanges information with other Trust and national systems. Failure or degradation could affect the availability, completeness or timely flow of information used in
patient administration, clinical documentation, diagnostics, theatre workflows and other care processes.
The direct award is based on the Trust's evidenced assessment of technical dependencies, lawful support position, interoperability requirements, transition activities and the risks associated with changing supplier before a safe replacement can be competitively procured and implemented.
The maximum term to 30 November 2029 is intended to provide a controlled period to maintain the incumbent service, confirm the future operating model, conduct a compliant procurement, implement the selected solution and complete a clinically safe transition and exit. The Trust will keep the timetable under review.
How it was run
Official notice- Submission deadline
- —
Timeline
18 Nov 2026 → 27 Nov 2026 · 2 dates- Notice published43h ago18 Nov 2026, 10:13 GMT
- Today20 Nov 2026
- Standstill endsin 7 days27 Nov 2026, 23:59 GMT
Notice history
3 events · 2 releases on Find a Tender · since 16 Nov 2026- Transparency notice published16 Nov 2026, 09:07 GMTUK5
- Contract award notice published18 Nov 2026, 10:13 GMTUK6
- Contract signature expected30 Nov 2026, 23:59 GMTscheduled
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- DH OPCO UK LTDAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedNotices published for this procedure
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender